Advertisement

Topics

Latest "ivWatch" News Stories

15:39 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "ivWatch" found in our extensive news archives from over 250 global news sources.

More Information about ivWatch on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ivWatch for you to read. Along with our medical data and news we also list ivWatch Clinical Trials, which are updated daily. BioPortfolio also has a large database of ivWatch Companies for you to search.

Showing "ivWatch" News Articles, all 10

Extremely Relevant

EU OKs ivWatch's intravenous infiltration/extravasation monitor

European regulators have granted ivWatch CE mark approval for its ivWatch Model 400, an intravenous infiltration/extravasatio -More- 


ivWatch Model 400 medical device secures CE Mark

The ivWatch Model 400 has been developed for continuous IV monitoring for the early detection of infiltration and extravasation events to enhance patient safety and minimize harm. The The post ivWatch Model 400 medical device secures CE Mark appeared first on Compelo Medical Devices.

ivWatch signs deal with ICU Medical to provide customers interoperability

The collaboration will offer a way forward for Electronic Health Records (EHR) interoperability by connecting the two companies’ systems in order to exchange and use high-quality data. ivWatch The post ivWatch signs deal with ICU Medical to provide customers interoperability appeared first on Compelo Medical Devices.


Relevant

ivWatch Receives CE Mark for the ivWatch Model 400

Recent regulatory approvals and global certification pave the way for international distribution ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, announced the CE marking of the ivWatch Model 400. In addition to conforming to European standards, the company ...

ivWatch Grows Global Intellectual Property Portfolio with Additional Patent Grants

Australian and Japanese grants bring owned patents to nine ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, recently had two patent applications granted by the Australian and Japanese Patent Offices expanding the company’s intellectual property (IP) portfo...

ivWatch Continues to Expand Global Patent Portfolio

New European and Japanese grants bring total to seven owned patents ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, received two patents granted by the European and Japanese Patent Offices expanding their intellectual property (IP) portfolio. The g...

ivWatch Extends Patient Monitor to International Markets

ivWatch, the only provider of continuous patient monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, announces a new international partner to manage distribution to support market expansion outside of the United States. Following the

ivWatch Enters into Agreement with ICU Medical to Offer Customers Interoperability

Agreement will allow ivWatch technology integration into new devices and systems ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, entered into a long-term development and commercialization agreement with ICU Medical, a worldwide leader in the development, ma...

Nationwide Children's Hospital Becomes First in Columbus with Continuous IV Monitoring Technology

Recent product implementation adds a new layer of care Patients at Nationwide Children’s Hospital, one of America’s largest not-for-profit freestanding pediatric health care systems, now have the latest enhancement for intravenous (IV) therapy with the installation of the

Speakers Highlight Quality Improvement and Patient-Centered Care Using ivWatch Technology

Fall speaking schedule delivers opportunities to hear from ivWatch experts and end-users Representatives and customers of ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, will share their experience and discuss current projects at several upcoming associatio...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks